LOADING
Latest News
Seven simple questionsHelp us improve your experience, delivering more of what you want
ESG Survey
Seven simple questions – Help us improve your experience, delivering more of what you want!
Tag: WuXi Biologics
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey
August 31, 2022
WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), today announced the release of its GMP phase I drug substance clinical manufacturing facility, MFG18, in Cranbury, New...
chat_bubble0 Comment
visibility46 Views
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
March 14, 2022
WuXi Biologics (“WuXi Bio”) (2269.HK), a global CRDMO service company, has been recognized as the Industry Top-Rated Company in 2022 by Sustainalytics, a global provider of Environmental, Social and Governance (ESG)...
chat_bubble0 Comment
visibility31 Views
trending_upTrending
whatshotPopular
then “Add to home screen”